Ginsenosides and gut microbiota: differential effects on healthy individuals and irritable bowel syndrome subtypes
The results elucidate the distinctive microbial signatures associated with ginsenosides treatment across both healthy and IBS-D groups, underscoring the potential therapeutic efficacy of ginsenosides in modulating gut microbiota. This study highlights the necessity for further investigation into targeted microbiome therapies for IBS, which may facilitate the development of more personalized and efficacious treatment strategies for gastrointestinal health.
Authors
- Du Zhi (ORCID: https://orcid.org/0000-0002-8704-3868)
- Guofei Ren (ORCID: https://orcid.org/0000-0001-5295-0110)
- Jing Peng (ORCID: https://orcid.org/0000-0001-7872-0946)
- Jing Miao (ORCID: https://orcid.org/0000-0002-2825-0648)
- Jiabin Li (ORCID: https://orcid.org/0000-0002-5308-5787)
- Yan Shen
- Jieying Ding (ORCID: https://orcid.org/0000-0002-0082-3678)
- Cheng Zhao (ORCID: https://orcid.org/0000-0001-9655-8866)
- Xiaoli Ye (ORCID: https://orcid.org/0000-0002-9635-3032)
Institutions
- Affiliated Hospital of Hangzhou Normal University (CN)
- Children's Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-04-15
- DOI
- https://doi.org/10.7717/peerj.19223
- Primary Topic
- Ginseng Biological Effects and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00